References:
1. Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, et al.
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive
Breast Cancer. N Engl J Med. 8 janv 2015;372(2):134‑41.
2. A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer
patient receiving weekly paclitaxel and trastuzumab - PubMed
[Internet]. [cité 24 août 2023]. Disponible sur:
https://pubmed.ncbi.nlm.nih.gov/21911478/
3. Philippin-Lauridant G, Clatot F, Rigal O, Laberge-Le-Couteulx S,
Guillemet C, Blot E. [Pneumocystis pneumonia in two breast cancer
patients treated with docetaxel: an unusual adverse event of
chemotherapy]. Rev Med Interne. avr 2010;31(4):e1-3.
4. Takeda K, Harada S, Hayama B, Hoashi K, Enokida T, Sasaki T, et al.
Clinical characteristics and risk factors associated with Pneumocystis
jirovecii infection in patients with solid tumors: study of
thirteen-year medical records of a large cancer center. BMC Cancer. 3
sept 2021;21(1):987.
5. Roblot F, Le Moal G, Kauffmann-Lacroix C, Bastides F, Boutoille D,
Verdon R, et al. Pneumocystis jirovecii pneumonia in HIV-negative
patients: a prospective study with focus on immunosuppressive drugs and
markers of immune impairment. Scand J Infect Dis. mars 2014;46(3):210‑4.
6. Wang Y, Zhou X, Saimi M, Huang X, Sun T, Fan G, et al. Risk Factors
of Mortality From Pneumocystis Pneumonia in Non-HIV Patients: A
Meta-Analysis. Front Public Health. 2021;9:680108.
7. Tolaney SM, Najita J, Winer EP, Burstein HJ. Lymphopenia associated
with adjuvant anthracycline/ taxane regimens. Clin Breast Cancer. août
2008;8(4):352‑6.
8. Classen AY, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M,
Graeff LD, et al. Primary prophylaxis of bacterial infections and
Pneumocystis jirovecii pneumonia in patients with hematologic
malignancies and solid tumors: 2020 updated guidelines of the Infectious
Diseases Working Party of the German Society of Hematology and Medical
Oncology (AGIHO/DGHO). Ann Hematol. juin 2021;100(6):1603‑20.
9. Corbaux P, Terret C, Cropet C, Chabaud S, Russo C, Faure C, et al.
Association of chemotherapy and comorbidities with overall survival in
elderly patients with early breast cancer: a French population-based
propensity score-matched analysis. Int J Clin Oncol. mars
2023;28(3):371‑81.
10. Predict Breast [Internet]. [cité 25 août 2023]. Disponible
sur: https://breast.predict.nhs.uk/tool
11. Kerr AJ, Dodwell D, McGale P, Holt F, Duane F, Mannu G, et al.
Adjuvant and neoadjuvant breast cancer treatments: A systematic review
of their effects on mortality. Cancer Treat Rev. avr 2022;105:None.